Advertisement

Topics

FDA to streamline access to direct-to-consumer genetic tests

08:08 EST 9 Nov 2017 | pharmaphorum

The FDA Commissioner, Scott Gottlieb, has unveiled plans to revamp the regulatory process for direct-to-consumer genetic tests, making it easier for them to make it to market.   The new process will allow genetic health risk (GHR) tests to bypas...

Original Article: FDA to streamline access to direct-to-consumer genetic tests

NEXT ARTICLE

More From BioPortfolio on "FDA to streamline access to direct-to-consumer genetic tests"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...